Physician profile
Bryan Young
NPI 1922580562
$1,425.77
in general payments reported to CMS, 2019-2025
15 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.88 · 2022: $81.95 · 2023: $473 · 2024: $651 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $565.74 | 2022-2024 | Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $236.80 | 2022-2025 | |
| Abbvie INC. | $126.81 | 2024 | |
| Novo Nordisk INC | $118.46 | 2024 | Wegovy |
| Lilly USA, LLC | $115.62 | 2021-2023 | Amyvid |
| Medtronic, INC. | $47.13 | 2025 | Reveal Linq, Linq II |
| Eisai INC. | $40.03 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $32.37 | 2025 | Eliquis |
| Pfizer INC. | $31.47 | 2023 | |
| Galderma Laboratories, L.P. | $23.10 | 2022 | |
| Exact Sciences Corporation | $21.44 | 2023 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $19.56 | 2023 | Inspire |
| Itamar Medical INC | $19.04 | 2023 | Watchpatone |
| Acella Pharmaceuticals, LLC | $14.45 | 2023 | NP Thyroid 60 |
| Biogen, INC. | $13.75 | 2024 | Leqembi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.